Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01562899
Title A Study of MEK162 and AMG 479 in Patients With Selected Solid Tumors
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Array BioPharma
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | CAN | BEL

Facility Status City State Zip Country Details
Massachusetts General Hospital Mass General 2 Boston Massachusetts 02114 United States Details
University of Utah / Huntsman Cancer Institute Huntsman Salt Lake City Utah 84103 United States Details
Pfizer Investigative Site Parkville Victoria 3050 Australia Details
Pfizer Investigative Site Leuven 3000 Belgium Details
Pfizer Investigative Site Toronto Ontario M5G 2M9 Canada Details
Pfizer Investigative Site Toulouse Cedex 9 31059 France Details
Pfizer Investigative Site Napoli 80131 Italy Details
Pfizer Investigative Site Barcelona Catalunya 08035 Spain Details
Pfizer Investigative Site Sutton Surrey SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field